Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF567 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GABRA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL12A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDCBP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UBXN10-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C10orf67 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HABP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PEX5L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3HAV1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LPXN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIRPG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL23A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on